Clearwater International advises Atypical Partner on the acquisition of a majority stake in Trueblue

Clearwater International has advised Atypical Partner, a pan-European investment platform with approximately €2.5bn in assets under management, on the acquisition of a majority stake in Trueblue, leading provider of software and artificial intelligence solutions for pharma and life science industries.

Founded in 2003 in Verona, Italy, Trueblue provides advanced software solutions based on proprietary technology integrated with artificial intelligence tools along with dedicated professional services targeting global life science clients. The company's core business is based on pharmaceutical sales force performance improvement tools that can integrate data from multiple sources and offer the user a 360-degree view of the customer, facilitating the implementation of a true omnichannel strategy through proactive contextual information processing, and real-time insights.

Atypical Partner is a pan-European investment platform dedicated to identifying and developing alternative capital strategies and is supported by an extensive network in the industry. The business currently holds Three Hills Capital Partners, a pioneer of hybrid capital strategy at European level, Pall Mall Legacy, a vehicle dedicated to solutions in the secondary market and Atypical Crew, an innovative vertical launched in 2022.

Atypical Partner will strengthen and consolidate the company’s international expansion, as well as further expand and innovate a product suite that is already highly innovative today, thanks also to the support of the strategic partnership with Microsoft, selected as the reference technology platform.